SPX4,064.79-15.32 -0.38%
DIA342.72-3.43 -0.99%
IXIC11,444.54-23.46 -0.20%

Susquehanna Maintains Positive on Endava, Raises Price Target to $120

Benzinga · 11/16/2022 06:58
Susquehanna analyst James Friedman maintains Endava (NYSE:DAVA) with a Positive and raises the price target from $110 to $120.